Radisson to Participate in The Gentile Mining Investor Forum in London 
3DG Jewellery Celebrates Its 23rd Anniversary in Dazzling Style 
Enablence Technologies Inc. Closes C$25 Million Strategic Investment 
TempraMed Reports Record July Sales and Strong August Performance, with Year-to-Date Sales Already Exceeding Full-Year 2025 Revenue 
TMD SPACE Launches ThailandCompanyDocs.com to Support Global Businesses Working with Thai Companies Enterprise Connect 2022 Successfully Brought the Enterprise Communications and Collaboration Industry Together to Learn and Network
Enterprise Connect 2023 is Scheduled for March 27-30, 2023 in Orlando, FL SAN FRANCISCO–(BUSINESS WIRE)–Enterprise…
Citi Foundation Announces $50 Million Community Finance Innovation Fund to Support the Growth of Community Development Financial Institutions Across the U.S.
New Request for Ideas, the largest in the Foundation’s history, aims to support innovative ideas…
OmniLife Partners With Redox to Add Patient Referral Management Tool to Its End-to-End Communication Platform for Transplant Hospitals.
OmniLife’s integrated communication and clinical workflow management platform has been helping Transplant Centers streamline organ…
Elsevier selects Conga to transform its global quote-to-cash processes
Global research publisher and information analytics provider optimises contract lifecycle and reduces contract generation time…
New Study Reveals How Desktop Delivery is Evolving in the Post-Pandemic Era
The Liquidware and IGEL sponsored study shows how the rapid migration to work-from-home during COVID-19…
Novan Announces Late-Breaking Abstract Accepted for Presentation at American Academy of Dermatology’s (AAD) 2022 Annual Meeting
DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops
Company poised for continued growth in a $6+ billion market¹ RALEIGH, N.C., March 24, 2022…
Revelation Biosciences Inc. Outlines Details on the Upcoming Data Analysis for Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx 99a for the Prevention of H3N2 Influenza Infection
-Primary endpoint analysis expected early Q2 2022- -Final data expected Q2 2022- SAN DIEGO, March…
Celsion Corporation to Hold Year-End 2021 Financial Results and Business Update Conference Call on Thursday, March 31, 2022
LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company…
Palisade Bio (Nasdaq: PALI) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group and Hosted by M-Vest
CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical…
SCYNEXIS to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Business Update
JERSEY CITY, N.J., March 24, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat” MIRAMAR, Fla.,…
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Developments
Validive® Phase 2b/3 VOICE Trial Continues Adding Sites in the U.S. and Europe Camsirubicin Phase…
Revolo Biotherapeutics to Participate at SVB Leerink Biopharma Private Company Connect
NEW ORLEANS and LONDON, March 24, 2022 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
VistaGen to Participate in Fireside Chat at Maxim Group 2022 Virtual Growth Conference
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (Nasdaq: VTGN)…
Immutep Announces Publication of TACTI-002 Abstract at ESMO’s European Lung Cancer Congress 2022
New interim data from TACTI-002 (Part B) evaluating the combination of efti and pembrolizumab in…
Longeveron Presents at Second Euro-Geroscience Conference
Longeveron management presents live at the Second Euro-Geroscience Conference and at a pre-meeting task force…
BioCardia to Host 2021 Financial Results and Corporate Update Conference Call on March 29, 2022
SUNNYVALE, Calif., March 24, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular…
Impel NeuroPharma Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Trudhesa™ Exceeds Fourth Quarter 2021 Prescription Guidance; Strong Launch Continues Into 2022 Demonstrated by 157%…
Ocuphire Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2021 and Provides Corporate Update
Building Momentum with Completion of Patient Enrollment in 4 Late-Stage Trials Multiple Late-Stage Clinical Trial…